Minirin (Desmopressin Acetate)

Desmopressin, the active ingredient in Minirin, is a vasopressin analog presented as an injectable solution for intramuscular, intravenous or subcutaneous use. It selectively increases water reabsorption in the kidneys and is employed to manage central diabetes insipidus, nocturnal enuresis, mild hemophilia A and von Willebrand disease in appropriate patients.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic pathway to correct water balance disorders. - Central diabetes insipidus: reduces excessive urine output by enhancing renal water reabsorption. - Nocturnal enuresis: decreases nighttime urine production, helping children and adults achieve dry nights. - Mild hemophilia A: raises plasma factor VIII levels to improve clot formation. - Von Willebrand disease: increases von Willebrand factor release, aiding haemostatic control.

Desmopressin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Hyponatraemia (mild): low sodium levels detectable on routine labs. - Facial flushing: transient redness of the skin. - Abdominal cramps: mild discomfort in the lower abdomen. - Nasal congestion: occasional blockage of nasal passages.

Serious or Rare Side Effects: - Severe hyponatraemia: can lead to confusion, seizures or coma. - Water intoxication: excessive fluid retention causing cerebral oedema. - Allergic reactions: rash, itching or anaphylaxis in rare cases. - Thrombotic events: rare clot formation reported in predisposed individuals.

Before prescribing Desmopressin, clinicians should consider several safety measures. - Monitor serum sodium: check electrolytes regularly, especially in the first weeks of therapy. - Adjust dose in renal impairment: reduced clearance may increase risk of hyponatraemia. - Limit fluid intake: advise patients to avoid excessive water consumption. - Use caution in the elderly: heightened susceptibility to fluid‑balance disturbances. - Contraindicated in patients with existing hyponatraemia: risk of worsening low sodium levels. - Store at room temperature: keep in the original container, protect from moisture and light.

Desmopressin can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism and reduces Desmopressin efficacy. - NSAIDs (e.g., ibuprofen): may potentiate hyponatraemia risk. - Other antidiuretic agents (e.g., chlorpropamide): additive effect on water retention.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and sodium levels. - SSRIs (e.g., fluoxetine): observe for signs of hyponatraemia. - Alcohol: may enhance hypotensive response, requiring caution.